Resmed (RSMDF) Change in Receivables (2009 - 2026)

Resmed (RSMDF) has reported Change in Receivables for 18 consecutive years, with $37.2 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Change in Receivables rose 613.5% year-over-year to $37.2 million; the trailing twelve-month figure through Jun 2026 stood at $96.8 million (up 26.2% YoY), and the FY2026 full-year result was $96.8 million, up 26.2% from the prior year.
• Change in Receivables rose to $37.2 million in Q2 2026 per RSMDF's latest filing, from $16.9 million in the prior quarter.
• Across five years, Change in Receivables topped out at $78.8 million in Q2 2022 and bottomed at -$36.4 million in Q3 2024.
• Historically, Change in Receivables has averaged $26.5 million across 5 years, with a median of $23.2 million in 2022.
• The sharpest annual moves came in 2024 and 2026: Change in Receivables slumped 457.35% in 2024, then jumped 613.5% in 2026.
• Over 5 years, Change in Receivables stood at $19.6 million in 2022, then soared by 36.85% to $26.8 million in 2023, then surged by 153.15% to $67.9 million in 2024, then increased by 7.12% to $72.7 million in 2025, then plunged by 48.81% to $37.2 million in 2026.
• According to Business Quant data, Change in Receivables over the past three periods registered $37.2 million, $16.9 million, and $72.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.